Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE

R Chang, CC Lai - JAMA, 2022 - jamanetwork.com
1. Pawar A, Gagne JJ, Gopalakrishnan C, et al. Association of type of oral anticoagulant
dispensed with adverse clinical outcomes in patients extending anticoagulation therapy …
相关文章

[引用][C] Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE

R Chang, CC Lai - JAMA, 2022 - pubmed.ncbi.nlm.nih.gov
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE Type of Oral …

Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE.

R Chang, CC Lai - JAMA, 2022 - europepmc.org
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE. - Abstract - Europe …